Argenx
ARGX
#542
Rank
A$57.84 B
Marketcap
$935.89
Share price
0.99%
Change (1 day)
62.15%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: A$57.84 Billion

As of April 2025 Argenx has a market cap of A$57.84 Billion. This makes Argenx the world's 542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025A$57.84 B-3.92%
2024A$60.21 B81.78%
2023A$33.12 B7.55%
2022A$30.79 B21.41%
2021A$25.36 B39.11%
2020A$18.23 B85.61%
2019A$9.82 B97.4%
2018A$4.97 B93.8%
2017A$2.56 B
2014A$0.17 B

End of Day market cap according to different sources

On Apr 24th, 2025 the market cap of Argenx was reported to be:

A$57.08 Billion
by Nasdaq info icon info icon
A$57.84 Billion
by CompaniesMarketCap info icon info icon
A$57.84 Billion
by Yahoo Finance info icon info icon